Monopar Therapeutics Inc (MNPR)

Monopar Therapeutics Inc (MNPR) Financial Statements


Monopar Therapeutics Inc Financial Overview

Monopar Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-0.711; its P/E ratio is -0.56; Monopar Therapeutics Inc is scheduled to report earnings on March 21, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -2.07M$ -2.33M$ -2.49M$ -2.94M$ -2.41M
EBITDA$ -2.07M$ -2.33M$ -2.49M$ -2.94M$ -2.41M
Net Income Common Stockholders$ -1.95M$ -2.20M$ -2.40M$ -2.93M$ -2.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.52M$ 7.21M$ 5.73M$ 8.19M$ 14.32M
Total Assets$ 8.59M$ 10.34M$ 11.83M$ 13.23M$ 14.45M
Total Debt$ 0.00$ 0.00$ 0.00$ 8.41K$ 20.85K
Net Debt$ -5.52M$ -7.21M$ -5.73M$ -8.18M$ -14.30M
Total Liabilities$ 1.98M$ 2.50M$ 2.89M$ 3.14M$ 1.94M
Stockholders Equity$ 6.61M$ 7.84M$ 8.94M$ 10.09M$ 12.51M
Cash Flow-
Free Cash Flow$ -1.94M$ -2.10M$ -2.27M$ -1.30M$ -2.15M
Operating Cash Flow$ -1.94M$ -2.10M$ -2.27M$ -1.30M$ -2.15M
Investing Cash Flow$ -13.05K$ 2.95M$ -983.44K$ -4.92M-
Financing Cash Flow$ 246.70K$ 641.18K$ 804.80K$ 138.74K$ -23.74K
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Monopar Therapeutics Inc Debt to Assets

Monopar Therapeutics Inc Cash Flow

Monopar Therapeutics Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis